The Investment Committee

Professor Michael Cardew-Hall (Chair)

Michael Cardew-Hall

Michael (Mick) Cardew-Hall has over 25 years experience as a Chartered Engineer, manager, academic and entrepreneur in the engineering, manufacturing and information technology fields.

He has held technical and managerial positions with leading UK companies such as GEC and Rolls-Royce PLC. He has held a number of academic positions including Professor and Head of Engineering at the ANU, Deputy Dean and Acting Dean of the College of Engineering and Computer Science. Mick has taught a wide range of management courses on Engineering and MBA programs in the area of project management, operations management, business planning and entrepreneurship. He has had extensive industrially focused research activities and leads the ANU group within the AutoCRC. He is currently a Director of Simile Systems Pty Ltd, a spin out company from his research activities at the ANU, which develops knowledge capture and management systems for manufacturing applications; the Australian Solar Institute; and Dosimetry and Imaging Pty Ltd. He holds a BSc(Hons) in Mechanical Engineering from the University of Nottingham and PhD and DIC from Imperial College London. He is currently part of the university executive at the ANU holding the position of Pro Vice-Chancellor (Innovation).

Dr Elaine Stead

Elaine SteadElaine is a life science technology commercialisation professional, with an extensive background in the identification, management and growth of early stage technology commercialisation. Elaine’s career has spanned the life science technology commercialisation continuum, including venture capital, public, private and start-up company senior management and University commercialisation. Elaine is currently VP of Corporate Development for ASX and NASDAQ listed company Sunshine Heart, and prior to this was Investment Manager with Australian life sciences venture capital fund, CM Capital for 4 years. Prior to joining CM Capital, Elaine was Deputy Director of Adelaide Research & Innovation Pty Ltd, the commercial arm of the University of Adelaide. Concurrently, she spent almost 3 years as CEO of medical device company, Reproductive Health Sciences Pty Ltd and raised angel and venture capital to support its development.  Elaine has a PhD (Biochemistry) from the University of Adelaide.

Simon Uzcilas

Simon Uzcilas is Director of Four Hats Capital and has over 15 years of private equity experience covering the sectors of venture, expansion, buyout and institutional investing. Throughout his career Simon has completed many equity and debt investments across a range of sectors including internet, new media, software, transport, manufacturing, food, infrastructure, mining and industrial services.

As a private equity investor, Simon has been on the board or as an observer on over thirteen portfolio companies. Simon has played a detailed hands-on role with many of Four Hats’ portfolio companies to assist in building value. His successful investments include Catapult Genetics which was sold Pfizer (NY) and PermissionCorp which is now a leading online permission marketing company. Other successful Four Hats investments include BTF (sold to bioMérieux of France) and QRx Pharma (ASX: QRX).

Simon has held previous roles at St.George Bank and BT Alex Brown (now Deutsche Bank). Simon graduated from UTS in Business and gained a Master of Commercial Law from University of Melbourne. He is also a CPA.

Comments are closed.